NDC 27808-315 – Cabergoline
Cabergoline .5 mg/1 · Tablet · Oral
Product NDC27808-315
Product details
- Brand name
- Cabergoline
- Generic name
- Cabergoline
- Labeler
- Cranbury Pharmaceuticals, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA220309
- Marketed since
- August 1, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Ergot Derivative
Active ingredients
- Cabergoline .5 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 27808-315-01 | 8 TABLET in 1 BOTTLE (27808-315-01) | Aug 1, 2026 |
Other Cabergoline products
- 50090-3157 Cabergoline .5 mg/1 · Tablet · A-S Medication Solutions
- 50090-5834 Cabergoline .5 mg/1 · Tablet · A-S Medication Solutions
- 50090-6596 Cabergoline .5 mg/1 · Tablet · A-S Medication Solutions
- 50090-7642 Cabergoline .5 mg/1 · Tablet · A-S Medication Solutions
- 69238-2693 Cabergoline .5 mg/1 · Tablet · Amneal Pharmaceuticals NY LLC
- 23155-823 Cabergoline .5 mg/1 · Tablet · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 50742-118 Cabergoline .5 mg/1 · Tablet · Ingenus Pharmaceuticals, LLC
- 59762-1005 Cabergoline .5 mg/1 · Tablet · Mylan Pharmaceuticals Inc.
- 70512-860 Cabergoline .5 mg/1 · Tablet · SOLA Pharmaceuticals, LLC
- 70069-824 Cabergoline .5 mg/1 · Tablet · Somerset Therapeutics, LLC
- 0093-5420 Cabergoline .5 mg/1 · Tablet · Teva Pharmaceuticals USA, Inc.